By Josh Beckerman
Autonomix Medical shares fell to their lowest point yet after the medical device company reported the pricing of a $9 million public offering.
The stock was recently down 53% to $6.31, with an intraday low of $5.85. Adjusted for an October reverse stock split, the company's January initial public offering priced at $100.
The company said Friday that the offering is comprised of 1.38 million common stock units, or pre-funded warrant units in lieu of common stock units, priced at $6.54 per common stock unit or $6.539 per pre-funded warrant unit. The units each have one share or pre-funded warrant plus one Series A warrant.
On Nov. 1, Autonomix filed to offer up to 698,812 common stock units.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
November 22, 2024 13:26 ET (18:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.